Patients with Parkinson’s disease (PD) who have a third level qualification have a higher medication compliance rate than those who do not, a study says.
Researchers in the US noted in the American Journal of Geriatric Pharmacology anti-Parkinson’s drugs (APDs) were the mainstay of disease management, but found the prevalence of their use was 58.2 per cent.
Data from a study of 571 patients with PD revealed educational status, age and whether they were residing in an institution were significant factors influencing medication compliance.
“Multivariate analyses found that patients 65 to 74 years of age and those more than 85 years of age were less likely to use APDs than patients aged 75 to 84 years of age.
“Patients who had attainted a high...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.